Table 1.

Distribution of novel drug approvals by designation and indication.

Source: FDA, Novel Drugs Approvals 2011–2015

	Non-oncology	Oncology	Total
Orphan drugs	36	35	71
Non-orphan drugs	58	53	111
Total	94	88	182